Literature DB >> 11502341

Preventing antiretroviral anarchy in sub-Saharan Africa.

A D Harries1, D S Nyangulu, N J Hargreaves, O Kaluwa, F M Salaniponi.   

Abstract

Combination antiretroviral therapy has dramatically improved the survival of patients living with HIV and AIDS in industrialised countries of the world. Despite this enormous benefit, there are some major problems and obstacles to be overcome.(1) Treatment of HIV-infection is likely to be lifelong.(2) Unfortunately, many HIV-infected individuals cannot tolerate the toxic effects of the drugs, or have difficulty complying with treatment which involves large numbers of pills and complicated dosing schedules. Poor adherence to treatment leads to the emergence of drug-resistant viral strains that need new combinations of drugs or new drugs altogether.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502341     DOI: 10.1016/s0140-6736(01)05551-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  47 in total

Review 1.  Priorities for antiretroviral therapy research in sub-Saharan Africa: a 2002 consensus conference in Zambia.

Authors:  Isaac Zulu; Paula Schuman; Rosemary Musonda; Elwyn Chomba; Kasonde Mwinga; Moses Sinkala; Maureen Chisembele; Peter Mwaba; Dorothy Kasonde; Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2004-07-01       Impact factor: 3.731

2.  An information system and medical record to support HIV treatment in rural Haiti.

Authors:  Hamish S F Fraser; Darius Jazayeri; Patrice Nevil; Yusuf Karacaoglu; Paul E Farmer; Evan Lyon; Mary Kay C Smith Fawzi; Fernet Leandre; Sharon S Choi; Joia S Mukherjee
Journal:  BMJ       Date:  2004-11-13

Review 3.  Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis.

Authors:  Anthony D Harries; Edwin Libamba; Erik J Schouten; Andrina Mwansambo; Felix M Salaniponi; Rex Mpazanje
Journal:  BMJ       Date:  2004-11-13

Review 4.  Antiretroviral adherence in a resource-poor setting.

Authors:  Catherine Orrell
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

5.  The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda.

Authors:  J T Crane; A Kawuma; J H Oyugi; J T Byakika; A Moss; P Bourgois; D R Bangsberg
Journal:  AIDS Behav       Date:  2006-07

Review 6.  Extending HIV care in resource-limited settings.

Authors:  Kara Wools-Kaloustian; Sylvester Kimaiyo
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

7.  Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?

Authors:  A Boulle; N Ford
Journal:  Sex Transm Infect       Date:  2007-12       Impact factor: 3.519

Review 8.  Adherence-resistance relationships to combination HIV antiretroviral therapy.

Authors:  David R Bangsberg; Deanna L Kroetz; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

9.  Treating our way out of AIDS?

Authors:  Mary T Bassett; Karen Brudney
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

10.  Explaining adherence success in sub-Saharan Africa: an ethnographic study.

Authors:  Norma C Ware; John Idoko; Sylvia Kaaya; Irene Andia Biraro; Monique A Wyatt; Oche Agbaji; Guerino Chalamilla; David R Bangsberg
Journal:  PLoS Med       Date:  2009-01-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.